|
|||||
|
|
In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3 |
|
| Authors: | Jana Schmidt,Thorsten Schmidt,Matthias Golla,Lisa Lehmann,Jonasz Jeremiasz Weber,Jeannette Hübener‐Schmid,Olaf Riess |
| Affiliation: | Institute of Medical Genetics and Applied Genomics and Center for Rare Diseases, University of Tuebingen, Tuebingen, Germany |
| Abstract: | |
| Keywords: | mouse model polyglutamine disease riluzole spinocerebellar ataxia type 3 |